Results 121 to 130 of about 1,580 (184)

Still at sea: a patient's ongoing journey with non-obstructive hypertrophic cardiomyopathy. [PDF]

Eur Heart J Case Rep
Goldie FC, Myles RC, Coats CJ.
europepmc   +1 more source

One- and two-year structural changes of mavacamten therapy in hypertrophic obstructive cardiomyopathy: a case report with serial comprehensive CMR demonstrating continuous reverse remodelling. [PDF]

Eur Heart J Case Rep
Seuthe K, Pfister R, Schönherr CH, Kaya K, Pennig L.   +4 more
europepmc   +1 more source

Mavacamten optimizes myocardial work in patients with obstructive hypertrophic cardiomyopathy: a non-invasive pressure-strain analysis. [PDF]

Clin Res Cardiol
Scholtz S, Coppée C, Mohemed K, Potratz M, Langkamp F, Rudolph V, Maack C, Scholtz W, Sequeira V, Reil JC.   +9 more
europepmc   +1 more source

CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy. [PDF]

Eur J Clin Pharmacol
Kasolo Y, Burford E, Obeidat M, Beaman GM, Monk T, Bastiaenen R, Newman WG, Cooper RM.   +7 more
europepmc   +1 more source

Long-Term Follow-Up After Discontinuation of Mavacamten in Hypertrophic Obstructive Cardiomyopathy. [PDF]

CJC Open
Yu M, Wang F, Pu L, Wang J, Chen Y.
europepmc   +1 more source

Mavacamten in Symptomatic Hypertrophic Cardiomyopathy

JACC: Asia
Chung-Lieh Hung, Yen-Wen Liu, Yen-Wen Wu
openaire   +1 more source

Mavacamten in Obstructive Hypertrophic Cardiomyopathy and C282Y Homozygous Hereditary Hemochromatosis: A First-in-Human Report. [PDF]

JACC Case Rep
Sam R, Ananthaneni A, Planek MI, Kogan A, Gordon R.   +4 more
europepmc   +1 more source

Association Between Baseline Hypertension and Longitudinal Functional Status in Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten. [PDF]

J Card Fail
Reza N, Mahmud N, Austin MA, Boakye E, Duqueney E, Patel P, DE Feria A, Hornsby N, Marzolf A, Owens AT.   +9 more
europepmc   +1 more source

Obstructive Hypertrophic Cardiomyopathy and Interarterial Anomalous Aortic Origin of the Right Coronary Artery (AAORCA) Presenting With Syncope: Multimodal Diagnostic Assessment and Individualized Management. [PDF]

Cureus
Moyambi J, Said Ismail AA, Jalal T, Meftout B, Abdenasser D.   +4 more
europepmc   +1 more source

Efficacy and Safety of Mavacamten and Aficamten in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. [PDF]

Crit Pathw Cardiol
Ibrahim M, Kashif A, Arfin SMW, Mubeen M, Zafar A, Balach R, Ahmed A, Musani MH, Greene SJ, Fonarow GC, Sohail MU.   +10 more
europepmc   +1 more source